CureVac Netherlands

Developing mRNA based cancer vaccines.

[CureVac Netherlands @CureVacNL]

HIRING - CureVac NL (part of @CureVacRNA) is looking for new talent! We seek to recruit a (Senior) Technician Genomics to support our cancer vaccine target discovery and validation projects. Please apply via https://t.co/AioZauWnzF

[CureVac Netherlands @CureVacNL]

Yesterday the Dutch Prime Minister Mark Rutte
@MinPres visited our company. He was much interested to hear how @CureVacRNA develops a novel cancer immunotherapy with a multinational team in an innovative and vibrant environment at Amsterdam Science Park @MATRIXIC.

[CureVac Netherlands @CureVacNL]

HIRING - CureVac NL (AMS) is looking for an enthusiastic lab technician with experience in immunological research who would like to work together with us on the development of mRNA based cancer vaccines. Please apply via https://t.co/0taRKauOh7 #labtechnician #antigendiscovery

[CureVac Netherlands @CureVacNL]

HIRING - CureVac Netherlands is seaching for a Scientist Immunology (PhD) to work in our Antigen Discovery and Validation Center of excellence. Please apply via https://t.co/56kRJEguKS #hiring #phd #immunology #immunotherapy #oncology #antigendiscovery #messengerRNA #curevac

[CureVac Netherlands @CureVacNL]

@WigardK, our Senior Director Antigen Discovery & Validation, will speak about Categorizing Most Effective Neoantigens to Ensure Greatest Clinical Benefits at the Neoantigen Based Therapies Summit in Boston, USA on October 26th. More info & program: https://t.co/UPbxfujN3l

[CureVac Netherlands @CureVacNL]

On Aug18 (11.15 EDT), our Associate Director Immunology Katka Franke will speak about the identification and validation of #neoantigens resulting from neo-open reading frames at the Cancer Vaccine Development Summit in Boston https://t.co/SqnrcsRz7T #immunooncology @CureVacRNA

[CureVac Netherlands @CureVacNL]

CureVac NL is #hiring. We are looking for #Bioinformatician to work together with us on the development of #mRNA based #cancer #vaccines. See details of who we are looking for and what we offer below. If you would like to apply, please mail to [email protected]. #curevac

[CureVac Netherlands @CureVacNL]

CureVac NL is #hiring. We are looking for a #Scientist #Immunology (PhD) to work together with us on the development of #mRNA based cancer vaccines. See details of who we are looking for and what we offer below. If you would like to apply, please mail to [email protected].

[CureVac Netherlands @CureVacNL]

Frame is now CureVac Netherlands BV. July 1 marks the official closing of the acquisition deal and as of today, Frame will no longer exist as a company. Read more on the acquisition and our future activities as CureVac NL via the link https://t.co/2cQohmyvBe

[CureVac Netherlands @CureVacNL]

We are proud to announce the acquisition of our company Frame Cancer Therapeutics by @CureVacRNA , a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”). See press release here: https://t.co/zQwCgWcNc3

[CureVac Netherlands @CureVacNL]

In Spring 2022, CSO @WigardK will be speaking on the identification of Frame neoantigens at the Neoantigen Summit in Amsterdam and on Frame’s experiences applying long-read sequencing at The Jackson Laboratory for Genomic Medicine in Farmington, USA. https://t.co/dbrxGHCobk

[CureVac Netherlands @CureVacNL]

Frame’s first clinical trial protocol has been approved! We have reached a major milestone as the CCMO has given Frame the green light to execute its first clinical trial in patients with advanced lung cancer. More info: https://t.co/euU4GPcTh2

[CureVac Netherlands @CureVacNL]

Recently Frame has shared its unique approach at several conferences related to developing novel cancer therapies. In the upcoming weeks we again proudly share the stage with well-known other scientists. More info: https://t.co/3zt3vfH2qu

[Ronald Plasterk @RPlasterk]

I will be speaking at the 6th Neoantigen Based Therapies Summit this October, I hope you can join! Check out the 3-day program in the full event guide here: https://t.co/CedoMcQUsF

[CureVac Netherlands @CureVacNL]

Frame CSO @WigardK will speak at the Europe NEOANTIGEN Summit 2021 on April 21st about the discovery of the full potential of Frame neoantigens as targets of cancer immunotherapy: Whole Framome cancer vaccination. More info: https://t.co/mzxvZuN27K

[CureVac Netherlands @CureVacNL]

Frame CEO @RPlasterk will speak about Whole Framome cancer vaccination and how fighting cancer by stimulating the immune system works at the @I4Hevent session ‘Innovations in Immuno-oncology' on March 15th. More info and abstract: https://t.co/Hq6F4y75an

[CureVac Netherlands @CureVacNL]

Open position: Frame Therapeutics is looking to hire a Chief Medical Officer. Please visit our website to check out the vacancy and to get in touch: https://t.co/Umwv4T9v3B

[CureVac Netherlands @CureVacNL]

eTheRNA immunotherapies & Frame Therapeutics collaboration to develop a therapeutic vaccine for the treatment of kidney cancer is awarded the Eurostars research grant for a total of EUR 1.9 million.

Read more: https://t.co/AIxL7sKfmX

[CureVac Netherlands @CureVacNL]

Join our team! In addition to the open position for a Scientist Immunology, Frame Therapeutics is also looking to hire a Medical Officer and a Clinical Trial Manager. Please visit our website to check out the positions and to get in touch: https://t.co/tsquznSmia

[CureVac Netherlands @CureVacNL]

Join our team! Frame Therapeutics is looking for a strong Scientist Immunology. Go to our website to check out the open position and to get in touch: https://t.co/gaP09vctIE